期刊文献+

MMP-9与慢性心力衰竭的相关性分析 被引量:3

下载PDF
导出
摘要 目的探讨血清基质金属蛋白酶-9(MMP-9)与慢性心力衰竭(CHF)的相关性。方法抽血检测118例气虚型纽约心脏病协会(NYHA)心功能Ⅲ级~Ⅳ级CHF病人血清MMP-9的含量,用相关分析的统计方法评价MMP-9与慢性心力衰竭的关系。结果 MMP-9(P=0.001)与心力衰竭相关,随着MMP-9数值的升高,心功能分级也升高,心力衰竭程度加重。MMP-9与BNP之间亦有良好的相关性(P=0.026)。结论 MMP-9与心力衰竭相关,是心力衰竭的一个准确性高的血浆蛋白标志物。
机构地区 广东省中医院
出处 《中西医结合心脑血管病杂志》 2011年第2期149-150,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 广州中医药大学创新基金资助项目(No.K0070065)
  • 相关文献

参考文献12

  • 1王先梅,杨丽霞,齐峰,魏玲,石燕昆,祝善俊,杨永健.心肌组织基质金属蛋白酶-3及其抑制物-1的表达与心功能损害[J].中华内科杂志,2002,41(7):453-455. 被引量:14
  • 2Reinhardt D,Siguseh HH,Hensse J,et al.Cardiac remodelling in end stage heart failure:Upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease,and evidence for a direct inhibitory effect of ACE inhibitors on MMP[J].Heart,2002,88(5):525-530.
  • 3金晶,任江华,曹茂银,赵伟涛.基质金属蛋白酶在心肌肥厚大鼠中的作用及强力霉素的干预效果[J].临床心血管病杂志,2006,22(12):738-741. 被引量:1
  • 4Detombe PP.Altered contractile function in heart failure[J].Cardiovasc Res,1998,37:367-380.
  • 5Tya SC.Extracellular matrix dynamics in heart failure:Aprospect for gene therapy[J].J Cell Biochem,1998,68:403-410.
  • 6Weber KT,Brilla CG.Pathological hypertrophy and cardiac interstitium:Fibrosis and rennin-angiotensin-aldosterone system[J].Circulation,1991,83:1849-1865.
  • 7Hornebeck W,Emonard H,Moboisse JC,et al.Matrix-diected regulation of pericellular proteolysis and tumor progression[J].Semin Cancer Biol,2002,2:231-241.
  • 8Fedak PW,Verma S,Weisel RD,et al.Cardiac remodeling and failure from molecules to man(Part Ⅱ)[J].Cardiovasc Pathol,2005,14:49-60.
  • 9Polyakova V,Hein S,Kostin S,et al.Matrix metalloproteinases and their tissue inhibitors in pressure overloaded human myocardium during heart failure progression[J].J Am Coll Cardiol,2004,44:1609-1618.
  • 10葛熙,陶国华,谢建培.MMP-2,9及TIMP-1与心力衰竭关系的实验研究[J].医学检验与临床,2008(4):29-31. 被引量:14

二级参考文献36

共引文献35

同被引文献34

  • 1Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:386
  • 2高卫真,康毅,娄建石,刘艳霞.黄芪苷Ⅳ对心肌细胞氧化损伤的保护作用[J].中国心血管杂志,2005,10(3):166-169. 被引量:39
  • 3Pincott ES,Burch M. New biomarkers in heart failure[J].Progress in Pediatric Cardiology,2011,(01):49-52.
  • 4Tobias JD. B-type natriuretic peptide:diagnostic and therapeutic applications in infants and children[J].Journal of Intensive Care Medicine,2011,(03):183-195.
  • 5Chan D,Ng LL. Biomarkers in acute myocardial infarction[J].BMC Medicine,2010.34.
  • 6Auerbach SR,Richmnd ME,Lamour JM. BNP levels predict outcome in pediatric heart failure patients:post-hoc analysis of the pediatric carvedilol trial[J].C irc Heart Fail,2010,(05):606-611.
  • 7Maisel AS,Krishnaswamy P,Nowak RM. Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure[J].New England Journal of Medicine,2002,(03):161-167.
  • 8Costello JM,Backer CL,Checchia PA. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure[J].Pediatric Cardiology,2004,(04):347-353.
  • 9Sugimoto M,Manabe H,Nakau K. The role of N-terminal Pro-Btype natriuretic peptide in the diagnosis of congestive heart failure in children[J].Circulation,2010,(05):998-1005.
  • 10Iwanaga Y,Miyazaki S. Heart failure,chronic kidney disease,and biomarkers——an integrated viewpoint[J].Circulation,2010,(07):1274-1282.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部